Peptides 101: What Are Peptides?

If you have spent any time reading about health optimization, metabolic medicine, or regenerative therapies, you have almost certainly encountered the word "peptide." The term shows up in clinical trials for diabetes, in anti-aging discussions, in sports medicine journals, and on supplement labels. Despite the widespread interest, many people remain unclear about what peptides actually are, how they work, and where they fit relative to other therapeutic molecules. This guide covers the fundamentals.

What Is a Peptide?

A peptide is a short chain of amino acids linked together by peptide bonds. Amino acids are the building blocks of all proteins in the body, and there are 20 standard amino acids encoded by human DNA. When two or more amino acids are joined end-to-end through a condensation reaction (where a water molecule is lost), the resulting covalent bond between the carboxyl group of one amino acid and the amino group of the next is called a peptide bond.[1]

By convention, a molecule is considered a peptide if it contains between 2 and approximately 50 amino acids. Below that range, you have individual amino acids. Above it, the molecule is generally classified as a protein. The boundary is not absolute -- some sources place the cutoff at 40, others at 100 -- but the 2-to-50 range is the most widely used definition in biochemistry and pharmacology.[2]

The sequence and number of amino acids in a peptide determine its three-dimensional shape, which in turn determines its biological activity. Even a single amino acid substitution can radically alter a peptide's function, receptor binding affinity, or half-life in the bloodstream.

Natural Peptides in the Human Body

Your body produces hundreds of bioactive peptides that regulate virtually every physiological system. These endogenous peptides act as hormones, neurotransmitters, growth factors, and immune modulators. Some of the most clinically significant examples include:

• Insulin (51 amino acids) -- produced by beta cells of the pancreas, insulin is the primary hormone that regulates blood glucose levels. It is arguably the most well-known peptide in medicine and was the first protein to have its amino acid sequence determined.[3]
• Oxytocin (9 amino acids) -- synthesized in the hypothalamus and released by the posterior pituitary, oxytocin plays essential roles in labor, lactation, social bonding, and stress response.
• GLP-1 (glucagon-like peptide-1, 30 amino acids) -- an incretin hormone released by L-cells in the gut after eating. GLP-1 stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and acts on brain satiety centers. Synthetic analogs of GLP-1 (semaglutide, tirzepatide) are now among the most prescribed drugs worldwide.
• Growth hormone-releasing hormone (GHRH) (44 amino acids) -- secreted by the hypothalamus to stimulate the anterior pituitary to release growth hormone (GH).
• Ghrelin (28 amino acids) -- the "hunger hormone," produced primarily by the stomach, which stimulates appetite and growth hormone release.
• Thymosin beta-4 (43 amino acids) -- found in virtually all tissues, it promotes cell migration, wound healing, and tissue repair.
• Defensins (29-45 amino acids) -- antimicrobial peptides produced by neutrophils and epithelial cells that form a key part of the innate immune system.

The sheer diversity of natural peptides illustrates why synthetic peptide therapeutics have such broad potential. By mimicking, enhancing, or blocking natural peptide signaling, researchers can target pathways involved in metabolism, tissue repair, immune function, sexual health, neurological function, and more.

How Peptides Differ from Proteins, Steroids, and Small Molecules

Understanding where peptides sit relative to other drug classes is critical for understanding their pharmacology, administration routes, and regulatory treatment. The following table summarizes the key differences:

One important nuance: insulin (51 amino acids) is technically at the borderline between peptide and protein, and it is sometimes classified as either. In clinical pharmacology, the term "peptide drug" typically refers to any amino acid-chain therapeutic regardless of whether it is above or below a strict 50-residue cutoff.

Synthetic Peptides

While the body produces peptides naturally, scientists can also synthesize them in the laboratory. Synthetic peptides can be exact copies of natural peptides, modified analogs designed for improved stability or potency, or entirely novel sequences that do not occur in nature.

Most synthetic peptides are manufactured using solid-phase peptide synthesis (SPPS), a technique pioneered by Robert Bruce Merrifield in 1963 (for which he won the Nobel Prize in Chemistry in 1984). In SPPS, amino acids are added one at a time to a growing chain anchored to an insoluble resin bead. This allows the chemist to precisely control the sequence and purify the product at each step.[4]

A major challenge with natural peptides is their short half-life. Enzymes called peptidases rapidly break down peptide chains in the bloodstream. To overcome this, pharmaceutical chemists use several strategies:

• Amino acid substitution -- replacing natural amino acids with non-natural analogs that resist enzymatic cleavage. Semaglutide, for example, uses an aminoisobutyric acid (Aib) substitution at position 8 to prevent DPP-4 degradation.
• Fatty acid acylation -- attaching a fatty acid chain that binds to albumin in the blood, creating a depot effect. This is how semaglutide achieves a half-life of approximately 7 days despite being a 39-amino-acid peptide.
• PEGylation -- attaching polyethylene glycol chains to shield the peptide from enzymatic degradation and renal clearance.
• Cyclization -- forming a circular peptide structure that is inherently more resistant to exopeptidases.
• Drug Affinity Complex (DAC) -- a chemical modification (as in CJC-1295 DAC) that enables binding to serum albumin, extending half-life from minutes to days.

Mechanism Categories

Peptide therapeutics can be grouped by how they exert their biological effects. The major mechanism categories include:

Receptor Agonists

These peptides bind to and activate specific cell-surface receptors, mimicking the action of an endogenous ligand. Examples include semaglutide (GLP-1 receptor agonist), bremelanotide/PT-141 (melanocortin-4 receptor agonist), and ipamorelin (ghrelin receptor agonist). This is the most common mechanism for FDA-approved peptide drugs.

Growth Factors and Tissue Repair Agents

Some peptides promote healing by upregulating cell migration, angiogenesis (new blood vessel formation), or extracellular matrix synthesis. BPC-157, a 15-amino-acid fragment of body protection compound found in gastric juice, and TB-500, a synthetic fragment of thymosin beta-4, fall into this category. Most tissue-repair peptides remain in the research stage and are not FDA-approved.

Antimicrobial Peptides (AMPs)

AMPs are part of the innate immune system. They disrupt microbial cell membranes, making it difficult for bacteria to develop resistance. Defensins, cathelicidins (like LL-37), and magainins are all natural AMPs under active investigation as alternatives to conventional antibiotics.

Hormonal Modulators

These peptides regulate the release of other hormones. Growth hormone-releasing peptides (GHRPs) and growth hormone-releasing hormone analogs (like CJC-1295) stimulate the pituitary gland to secrete more growth hormone. Gonadotropin-releasing hormone (GnRH) analogs are used in fertility treatment and certain cancers.

Enzyme Inhibitors

Some peptides work by blocking enzymatic activity. ACE inhibitors (such as captopril, which was designed by modeling the peptide venom of the Brazilian pit viper) lower blood pressure by preventing the conversion of angiotensin I to angiotensin II.

Regulatory Classifications

Not all peptides have the same legal or regulatory status. Understanding these categories is essential for anyone researching or considering peptide therapies:

FDA-Approved Peptide Drugs

These are peptides that have completed the full FDA approval process including Phase I, II, and III clinical trials, and have demonstrated safety and efficacy for specific indications. They are available by prescription from licensed pharmacies. Examples include semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), bremelanotide (Vyleesi), and many older peptide drugs like octreotide and leuprolide. For a broader discussion, see our legal landscape guide.

Compounded Peptides

Compounding pharmacies can prepare custom peptide formulations under Section 503A or 503Peptides Know How Food, Drug, and Cosmetic Act. These are typically prescribed by a physician for an individual patient and prepared by a licensed pharmacist. The regulatory landscape for compounded peptides has been evolving rapidly, particularly for compounded versions of semaglutide and tirzepatide.

Research Chemicals

Peptides sold as "research chemicals" or "for research use only" are not approved for human use and are sold by chemical suppliers for laboratory investigation. They have not undergone clinical trials, and their purity, sterility, and safety are not guaranteed by any regulatory body. Purchasing and possessing research chemicals is generally legal, but administering them to humans falls outside the approved regulatory framework.

Further Reading

This overview provides the foundation for understanding the peptide articles throughout Peptides Know How. For deeper dives into specific topics, see:

• How to Reconstitute Lyophilized Peptides -- practical handling instructions
• SubQ and IM Injection Safety -- proper injection technique
• Guide to Insulin Syringes -- choosing and reading syringes
• How to Read a Certificate of Analysis -- evaluating peptide purity
• Legal Landscape of Peptides -- regulations and compliance
• Glossary of Peptide Terms -- definitions of key terminology

Video Resources

These videos from trusted educators provide additional context on the topics covered in this guide.